Aug 02 (Reuters) - Fulgent Genetics Q2 operating income USD -18.906 million.

• Q2 pretax profit USD -11.214 million
• Q2 operating expenses USD 45.397 million
• Q2 gross profit USD 26.491 million
• Q2 core revenue USD 70.2 million

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.